ClinicalTrials.gg
CompletedNCT04467554T-ChairUpdated Jan 28, 2022

Providing Sitting Balance Training With a Newly Developed Rehabilitation Device

An interventional study of T-chair in Stroke, sponsored by KU Leuven. Completed at 1 site in Belgium. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2022-01-28.

Sponsored by KU Leuven · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 110 Years
Sex
All
01

Study summary

This clinical study is being conducted to evaluate a new training device, the T-CHAIR, for trunk rehabilitation and post-stroke balance. The investigators would like to study three objectives. First, the investigators want to examine whether training with a new training device is feasible and safe during rehabilitation in the later phase, more than six months after a stroke. The investigators also evaluate whether training with a new training device has an effect on the sitting balance and the function and strength of the trunk. Finally, the investigators examine whether training with a new training device has an effect on walking, standing and activities of daily life and self-care.

Read the detailed description

The primary goal of this study is to evaluate safety, acceptance and feasibility when participants in the chronic phase after a stroke train with this newly developed trainings device. Secondly, the investigators will evaluate the effect of training with this device on secondary outcome parameters such as trunk function, standing and sitting balance, gait and selective movement. The investigators compare the effect on secondary outcomes of the experimental intervention with a control intervention using a randomized controlled trial. Both groups include participants in the chronic phase post-stroke.

TRIAL OBJECTIVES AND PURPOSE

The primary objective of the proposed project is to investigate the feasibility and safety of sitting balance training on the T-chair, in the chronic phase (>6 months) after stroke.

The second objective of the study is to investigate if utilizing the T-chair has an effect on sitting balance, trunk function and trunk strength in participants post stroke, in comparison to conventional therapy.

Thirdly, the investigators will examine if training on the T-chair has an effect on other parameters, such as gait, balance, activities of daily living and reintegration in community.

TYPE AND DESIGN OF THE TRIAL WITH HYPOTHESIS

This study is a monocenter randomized controlled trial, evaluating participants in the chronic phase (>6 months) after stroke. This study will be performed in a rehabilitation center (outpatient department) in Belgium. In this study two groups will be included; the experimental group will receive usual therapy plus additional training on the T-chair, the control group will receive usual therapy only. The investigators believe this is feasible to provide only additional therapy in the experimental group, as our trial is designed to examine the effect of a specific type of additional therapy (independent sitting balance training), and not to compare the effect of one therapy over another kind of therapy.

Hypotheses:

  1. The T-chair is a safe and feasible training device, to train trunk function in the subacute and chronic phase after stroke.
  2. Training on the T-chair has a positive effect on trunk function and strength compared to conventional therapy.
  3. Training on the T-chair has a positive effect on balance, gait, walking endurance, walking speed, activities of daily living, level of disability and change in patient status compared to conventional therapy.

ASSESSMENT

Data such as age, date of stroke, type of stroke, localization of stroke, comorbidities, dominant hand, educational level and gender are registered. Testing will be performed three times.

Two test moments at baseline, with an interval of 2 weeks. The third test moment will be conducted after the after the four weeks intervention.

The investigators evaluate feasibility and effect of sitting balance training with different standardized measures. All the outcome measures will be assessed using clinical measurement tools, whereby the investigators evaluated trunk selectivity and strength, leg selectivity and strength, walking abilities, level of functional performance and balance. Trunk strength will be assessed with a hand dynanometer and trunk stability with a balance platform BioRescue (RM Ingénierie, France).

The psychometric properties of the majority of the measurement tools were evaluated through a literature search. The investigators found a high interrater reliability, ranging from 0.74 to 0.99 and an excellent test-retest reliability, ranging from 0.90 to 0.99.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • Rehabilitation
  • Chronic phase
  • feasibility
  • randomized controlled trial
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's enrollment of 30 is below the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

KU Leuven is the lead sponsor of 371 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. First major stroke event, a transient ischemic attack or a previous stroke with full recovery is allowed.
  2. Impairment of the trunk function, with a maximum score of 19 on the trunk impairment scale .
  3. Able to maintain seated position for more than 10 seconds.
  4. Able to come to the rehabilitation ward as a chronic patient.
  5. More than six months after a stroke event.
  6. Older than 18 years.
  7. With no comorbidities other than stroke affecting trunk function. Comorbidities could be musculoskeletal problems or other neurological diseases.
  8. With sufficient cognitive and language capacity to perform the assessment.

Exclusion criteria

Exclusion Criteria:

  1. Not able to give informed consent.
  2. Not approved informed consent.
  3. Subject does not understand the study procedures.
  4. Subject has any history of another major neurological disorder.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Measurements and T-chair training

    This group will receive three measurements sessions and training with a new developed device (15 therapy sessions in total).

    Device: T-chair

  • No intervention
    Measurements

    This group will receive three measurements sessions.

Interventions

  • DeviceT-chair

    Participants will receive 15 sessions of intervention, four weeks in total with a duration of one hour for each session. The focus of the intervention will be trunk rehabilitation.

06

What researchers measure

Primary outcomes

  1. Recruitment

    Recruitment is characterized by the number of possible participants divided by the number of participants actually participated in the trial.

    Time frame: Through study completion, an average of 1.5 months.

  2. Retention

    Retention is the number of participants that complete the whole trial divided by the number of participants that are included in the study.

    Time frame: Through study completion, an average of 1.5 months.

  3. Participation

    During each therapy the therapist evaluates the participation of each candidate.

    Time frame: Through study completion, an average of 1.5 months.

  4. Adherence

    After each therapy session the therapist evaluates the adherence using the Clinician Rating of Compliance Scale. This is a seven point ordinal scale which assesses the level of adherence of the patient. A higher score represent better adherence. A score lower than five is defined as non-adherent.

    Time frame: Through study completion, an average of 1.5 months.

  5. Acceptability and enjoyment

    The level of enjoyment during the training will be assessed using the physical activity enjoyment scale. This scale contains 18 items, during the training participants have to score how they feel about the training on a seven-point bipolar scale. The lowest score stands for less enjoyment or acceptance, a higher score stands for maximum enjoyment or acceptance.

    Time frame: Through study completion, an average of 1.5 months.

  6. Safety and Adverse events

    Safety is evaluated by retaining all adverse events during the therapy sessions.

    Time frame: Through study completion, an average of 1.5 months.

  7. Device development or modifications

    Feedback from the participants and therapists to improve the device are noted after every session. Each patient and therapist who came in contact with the device received an experience questionnaire. The questionnaire contains 16 questions, 3 questions and 13 categorical questions on 5 or 7 point Likert scale.

    Time frame: Through study completion, an average of 1.5 months.

  8. Fatigue

    After each training session fatigue will be evaluated using Visual Analog Fatigue Scale.This scale consists of a 10 cm horizontal line with written description at each end of the line. The written description varies from no fatigue to Very Severe Fatigue on top of the 10 cm line.

    Time frame: Through study completion, an average of 1.5 months.

  9. Patient Global Impression of Change

    The patient Global impression of change is a one single question to rate their condition after the therapy sessions compared to the rate of their condition at the start of the therapy session. This scale will be evaluated twice. One time after two weeks of intervention and once after the four weeks of intervention.

    Time frame: Through study completion, an average of 1.5 months.

Secondary outcomes

  1. Trunk function

    The trunk impairment scale evaluates static and dynamic sitting balance and trunk coordination. The trunk impairment scale scores the trunk function based on 17 items on an ordinal scale. A higher score indicates a better trunk function. The maximum score on this scale is 23 points.

    Time frame: Through study completion, an average of 1.5 months.

  2. Trunk stability

    This will be done by performing the modified functional reaching task. More distance is a better outcome.

    Time frame: Through study completion, an average of 1.5 months.

  3. Trunk strength

    We measure strength in Newton with a hand-held dynamometer (MicroFet 2) of a variety of trunk muscle groups. A higher values stands for a better outcome.

    Time frame: Through study completion, an average of 1.5 months.

  4. Sitting balance

    The limits of stability will be evaluated using the balance platform BioRescue or similar measurement.

    Time frame: Through study completion, an average of 1.5 months.

  5. Walking speed

    Walking at comfortable speed and at maximum speed. Each condition will be performed three times. Patient safety will be guaranteed by a therapist walking next to the patient. Walking speed will also be registered using the GAITRite, which is a CE-marked rehabilitation device.

    Time frame: Through study completion, an average of 1.5 months.

  6. Walking capacity

    The functional ambulation categories examines the level of walking capacity. This test is a six-point scale. It ranges from non-functional walking to walking independently on an unstable surface. At first, we evaluate in this test if the participant is able to walk with or without aid or supervision of two or one therapists. If this is possible, then the assessor evaluates if walking is possible only on an even (indoor) or uneven (outdoor) surface. In this test, the participants will be allowed to use a walking aid. A higher level stands for better walking abilities.

    Time frame: Through study completion, an average of 1.5 months.

  7. Walking endurance

    We evaluate the endurance of walking by using the two-minute walk test (2MWT). The participants walk for two minutes at a standardized indoor walking track and may use a walking aid.

    Time frame: Through study completion, an average of 1.5 months.

  8. Lower extremities strength

    We measure strength in Newton with a hand-held dynamometer (MicroFet 2) of a variety of lower limb muscle groups.

    Time frame: Through study completion, an average of 1.5 months.

  9. Selective movements of the lower extremities and coordination

    We utilize the Fugl-Meyer assessment scale to evaluate selective movements of both the lower extremities.The motor score for the extremities includes assessment of reflex reactions, coordination as well as movements of the shoulder, elbow, wrist, hip, knee and ankle joint. The scoring ranges from 0-34 for selective movements and coordination of the lower extremities and 66 for selective movements and coordination of the upper extremities. A higher score represents a better motor function. We collect the total score and sub scores.

    Time frame: Through study completion, an average of 1.5 months.

  10. Balance

    The Berg Balance scale scores sitting and standing balance based on 14 items. The score ranges from 0 to 56. For each item, the scoring is possible on a 4-point ordinal scale. A higher score represents a better outcome.

    Time frame: Through study completion, an average of 1.5 months.

  11. Number of falls

    Participants in this study all receive an agenda to note the number of falls and the circumstances of the falls. During the four study weeks they have to fill in the agenda when a fall or an almost fall incident occurs.

    Time frame: Through study completion, an average of 1.5 months.

07

Study locations

1 site
  • Liselot Thijs
    Leuven, 3000, Belgium
08

References and documents

Publications

  • Thijs L, Voets E, Wiskerke E, Nauwelaerts T, Arys Y, Haspeslagh H, Kool J, Bischof P, Bauer C, Lemmens R, Baumgartner D, Verheyden G. Technology-supported sitting balance therapy versus usual care in the chronic stage after stroke: a pilot randomized controlled trial. J Neuroeng Rehabil. 2021 Jul 28;18(1):120. doi: 10.1186/s12984-021-00910-7. PubMed 34321042 ↗

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04467554
Lead sponsor
KU Leuven
Responsible party
Prof Geert Verheyden (Professor, KU Leuven) — Principal investigator
First posted
Jul 13, 2020
Start date
Jul 17, 2020
Primary completion
Dec 18, 2020
Completion
Jul 13, 2021
Last update
Jan 28, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion